Merck acquires Amnis Corporation

Published: 30 Aug 2011

Merck Millipore, known as EMD Millipore in the US and Canada, is to acquire Amnis Corporation, a US-based manufacturer of cell imaging systems.

Merck Millipore is the life sciences division of German pharmaceutical firm Merck.

The transaction is expected to take place before the end of 2011 according to Amnis, with financial terms undisclosed.

Amnis had revenue of $14m (€10m) in 2010 developing, manufacturing and marketing tools for high speed cell imaging for research and diagnostic markets.

Jonathan DiVincenzo, head of the bioscience business unit within Merck Millipore said: "The acquisition of Amnis significantly contributes to our strategy to be a leader in cellular analysis and systems biology."

David A Basiji, co-founder and CEO of Amnis said: "The combination of Amnis with EMD Millipore will greatly accelerate development of novel applications in imaging flow cytometry, enhance our customer support, and accelerate product development."

Published: 30 Aug 2011

Comments are moderated and will not appear until approved by a member of the Communique team.